| scholarly article | Q13442814 |
| P50 | author | Rodrigo Medeiros | Q38360409 |
| P2093 | author name string | Thomas E Lane | |
| David Cheng | |||
| Masashi Kitazawa | |||
| Frank M Laferla | |||
| Lucia Whitman | |||
| Michael Sy | |||
| P2860 | cites work | Role of Infection in the Pathogenesis of Alzheimerʼs Disease | Q22305814 |
| Vascular risk factors and dementia: how to move forward? | Q24650263 | ||
| Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B | Q27860731 | ||
| Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model | Q28115206 | ||
| Inflammation and Alzheimer's disease | Q28138617 | ||
| Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation | Q28267897 | ||
| Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain | Q28283487 | ||
| GSK-3beta is required for memory reconsolidation in adult brain | Q28473886 | ||
| Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway | Q28571359 | ||
| Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction | Q28575776 | ||
| Adverse stress, hippocampal networks, and Alzheimer's disease | Q33708011 | ||
| Herpes simplex virus type 1 in Alzheimer's disease: the enemy within | Q34011777 | ||
| Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice | Q34076162 | ||
| Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. | Q53390124 | ||
| Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology | Q34169743 | ||
| Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease | Q34386095 | ||
| Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain | Q34531006 | ||
| Lithium delays progression of amyotrophic lateral sclerosis | Q34746211 | ||
| Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles | Q35757220 | ||
| Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau | Q35911885 | ||
| Toward a remembrance of things past: deciphering Alzheimer disease. | Q36177528 | ||
| Lithium induces autophagy by inhibiting inositol monophosphatase | Q36321015 | ||
| Evidence for differential roles for NKG2D receptor signaling in innate host defense against coronavirus-induced neurological and liver disease | Q36484117 | ||
| Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years | Q36568136 | ||
| It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease | Q36586288 | ||
| Inflammation in Alzheimer disease: driving force, bystander or beneficial response? | Q36589042 | ||
| Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation | Q36916025 | ||
| Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration | Q37347086 | ||
| Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? | Q37533353 | ||
| Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice | Q37867591 | ||
| Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy | Q39889005 | ||
| Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. | Q40005542 | ||
| Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly | Q40878824 | ||
| Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression | Q41698055 | ||
| Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. | Q43919852 | ||
| Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. | Q44820147 | ||
| Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis | Q44897054 | ||
| Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation | Q45399423 | ||
| Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease | Q45756711 | ||
| Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. | Q45850723 | ||
| Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta | Q46135029 | ||
| T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection | Q46255462 | ||
| Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. | Q46303283 | ||
| Temporal correlation of the memory deficit with Alzheimer-like lesions induced by activation of glycogen synthase kinase-3. | Q46471659 | ||
| Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice | Q46663967 | ||
| Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses | Q48130989 | ||
| Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice | Q48196554 | ||
| Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease | Q48247414 | ||
| The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation | Q48486318 | ||
| Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein | Q49056858 | ||
| Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. | Q53189340 | ||
| Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. | Q53213552 | ||
| Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice. | Q53264743 | ||
| Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. | Q53297957 | ||
| Relationship between Helicobacter pylori infection and Alzheimer disease. | Q53378097 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 2811-2822 | |
| P577 | publication date | 2011-04-30 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Inflammation induced by infection potentiates tau pathological features in transgenic mice | |
| P478 | volume | 178 |
| Q90932824 | A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy |
| Q39039980 | A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease. |
| Q30387426 | Ameliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain Injury |
| Q35127516 | Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature |
| Q30415876 | Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease |
| Q36449877 | Can infections cause Alzheimer's disease? |
| Q42099062 | Chronic Intermittent Hypoxia Induces Chronic Low-Grade Neuroinflammation in the Dorsal Hippocampus of Mice |
| Q36338186 | Chronic lithium feeding reduces upregulated brain arachidonic acid metabolism in HIV-1 transgenic rat. |
| Q47110701 | Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy |
| Q91819984 | Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer's disease |
| Q37694042 | Enhanced susceptibility of triple transgenic Alzheimer's disease (3xTg-AD) mice to acute infection. |
| Q36109697 | Exendin-4 protected against cognitive dysfunction in hyperglycemic mice receiving an intrahippocampal lipopolysaccharide injection. |
| Q30540833 | Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease |
| Q38126701 | Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments |
| Q42670350 | Gut microbiome alterations in Alzheimer's disease |
| Q91925989 | HHV-6A infection induces amyloid-beta expression and activation of microglial cells |
| Q26781578 | Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease |
| Q34026390 | Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus |
| Q37039488 | Hydrogen sulfide protects against amyloid beta-peptide induced neuronal injury via attenuating inflammatory responses in a rat model |
| Q40757303 | IFN-γ promotes τ phosphorylation without affecting mature tangles |
| Q47865475 | In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510. |
| Q90479650 | Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation |
| Q34547897 | Inflammasomes as therapeutic targets for Alzheimer's disease |
| Q58700943 | Inflammation: the link between comorbidities, genetics, and Alzheimer's disease |
| Q38358574 | Innate immunity in Alzheimer's disease |
| Q91660737 | Intersection of pathological tau and microglia at the synapse |
| Q38569669 | Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents. |
| Q38724561 | LISPRO mitigates β-amyloid and associated pathologies in Alzheimer's mice. |
| Q36781712 | LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals |
| Q93046117 | Lipopolysaccharide exposure during late embryogenesis triggers and drives Alzheimer-like behavioral and neuropathological changes in CD-1 mice |
| Q36769080 | Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders |
| Q48777899 | Long-term cerebral consequences of sepsis |
| Q64087505 | MicroRNAs and the Genetic Nexus of Brain Aging, Neuroinflammation, Neurodegeneration, and Brain Trauma |
| Q41014561 | Microglia function in Alzheimer's disease |
| Q34114020 | Microglia in Alzheimer's disease |
| Q26739495 | Microglial Priming and Alzheimer's Disease: A Possible Role for (Early) Immune Challenges and Epigenetics? |
| Q37905130 | Modelling early responses to neurodegenerative mutations in mice |
| Q34631209 | Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism |
| Q38184606 | Modulation of inflammation in transgenic models of Alzheimer's disease |
| Q37627877 | Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase |
| Q36534100 | Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin |
| Q36084187 | Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide |
| Q36255465 | Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats |
| Q40607244 | No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau). |
| Q50856591 | Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. |
| Q41600247 | Progranulin reduction is associated with increased tau phosphorylation in P301L tau transgenic mice |
| Q93197465 | Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy |
| Q58697971 | Repurposing Proteostasis-Modifying Drugs to Prevent or Treat Age-Related Dementia: A Systematic Review |
| Q43136005 | Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model |
| Q99585601 | Restoring regulatory T-cell dysfunction in Alzheimer's disease through ex vivo expansion |
| Q47104106 | Rhinacanthin C Alleviates Amyloid-β Fibrils' Toxicity on Neurons and Attenuates Neuroinflammation Triggered by LPS, Amyloid-β, and Interferon-γ in Glial Cells |
| Q42580157 | Spotlight on nano-theranostics in South Korea: applications in diagnostics and treatment of diseases |
| Q39017112 | Stressed and Inflamed, Can GSK3 Be Blamed? |
| Q37631468 | Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents |
| Q37334378 | Systemic and localized extra-central nervous system bacterial infections and the risk of dementia among US veterans: A retrospective cohort study |
| Q92005936 | Tau as a potential therapeutic target for ischemic stroke |
| Q53403638 | The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer's Disease. |
| Q39149587 | The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy. |
| Q38555411 | The Role of PGRN in Alzheimer's Disease |
| Q39052041 | The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases |
| Q34410713 | The role of tau protein in HIV-associated neurocognitive disorders |
| Q24626017 | Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder |
Search more.